ArticleFrontiers in allergy2024

Innovations in the management of epistaxis secondary to hereditary hemorrhagic telangiectasia: our evolution to injection sclerotherapy as the treatment of choice.

Nitish Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.